Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. EXPO
EXPO logo

EXPO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Exponent Inc (EXPO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
70.100
1 Day change
0.10%
52 Week Range
84.000
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Exponent Inc (EXPO) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows modest growth in revenue and net income, insider selling and lack of strong trading signals suggest caution. The technical indicators do not indicate a clear upward trend, and the stock appears fairly valued at its current price. Analysts have mixed views, with some upside potential, but the lack of recent news or significant catalysts makes this a hold rather than a buy.

Technical Analysis

The MACD is positive and expanding, suggesting a bullish trend, but RSI is in the neutral zone at 66.721, indicating no clear signal. Moving averages are converging, showing no strong directional trend. The stock is trading near its resistance level (R1: 74.233), which could limit immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
1

Positive Catalysts

  • JPMorgan has an Overweight rating with a $100 price target, indicating 35% upside potential.

Neutral/Negative Catalysts

  • Insider selling has increased by 370.29% over the last month, which could indicate lack of confidence from management. Hedge funds are neutral, and there are no significant trading trends. Gross margin dropped to 0 in the latest quarter, which is a concerning financial metric.

Financial Performance

In Q4 2025, revenue increased by 4.54% YoY to $129.38M, net income rose by 4.97% YoY to $24.76M, and EPS grew by 6.52% YoY to 0.49. However, gross margin dropped to 0, which is a significant negative.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed ratings. UBS maintains a Neutral rating with a price target of $85, while JPMorgan initiated coverage with an Overweight rating and a $100 price target, citing potential for a strong rebound in fundamentals and valuation normalization.

Wall Street analysts forecast EXPO stock price to rise
3 Analyst Rating
Wall Street analysts forecast EXPO stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 70.030
sliders
Low
81
Averages
85.5
High
90
Current: 70.030
sliders
Low
81
Averages
85.5
High
90
UBS
Joshua Chan
Neutral
maintain
$81 -> $85
AI Analysis
2026-02-09
Reason
UBS
Joshua Chan
Price Target
$81 -> $85
AI Analysis
2026-02-09
maintain
Neutral
Reason
UBS analyst Joshua Chan raised the firm's price target on Exponent to $85 from $81 and keeps a Neutral rating on the shares. The Q4 results and 2026 guidance were largely consistent with consensus, but given that guidance typically leans conservative, there could be perceived upside potential through the year against a stock that has de-rated over much of the past year, the analyst tells investors in a research note.
JPMorgan
Tomohiko Sano
Overweight
initiated
$100
2026-01-26
Reason
JPMorgan
Tomohiko Sano
Price Target
$100
2026-01-26
initiated
Overweight
Reason
JPMorgan analyst Tomohiko Sano initiated coverage of Exponent with an Overweight rating and $100 price target, representing 35% upside potential. Exponent is a leader in science and engineering consulting, serving over 2,000 clients across 17 primary practices, the analyst tells investors in a research note. The firm says the company is positioned for a "strong rebound," with its revenue growth projected to accelerate to 9.5% in 2026 and margin expansion as headwinds ease and utilization improves. The stock offers potential upside as Exponent's fundamentals recover and valuation normalizes, contends JPMorgan.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EXPO
Unlock Now

People Also Watch